APPENDIX C – ROYALTIES Sample Clauses

APPENDIX C – ROYALTIES. Royalties:
Sample 1Sample 2Sample 3See All (58)
AutoNDA by SimpleDocs
APPENDIX C – ROYALTIES. Royalties: The Licensee agrees to pay to the IC a noncreditable, nonrefundable license issue royalty in the amount of ________ dollars ($X) within sixty (60) days from the effective date of this Agreement. The Licensee agrees to pay to the IC a nonrefundable annual royalty in the amount of ________ dollars ($X) as follows: The first annual royalty is due within sixty (60) days of the effective date of this Agreement and may be prorated according to the fraction of the calendar year remaining between the effective date of this Agreement and the next subsequent January 1; and Subsequent annual royalty payments are due and payable on January 1 of each calendar year.
Sample 1Sample 2Sample 3
APPENDIX C – ROYALTIES. Royalties: The Licensee agrees to pay to the IC a noncreditable, nonrefundable license issue royalty in the amount of _______ Dollars ($X) within sixty (60) days from the effective date of this Agreement. The Licensee agrees to pay to the IC a nonrefundable minimum annual royalty in the amount of _______ Dollars ($X) as follows: The first minimum annual royalty is due within sixty (60) days of the effective date of this Agreement and may be prorated according to the fraction of the calendar year remaining between the effective date of this Agreement and the next subsequent January 1; and Subsequent minimum annual royalty payments are due and payable on January 1 of each calendar year and may be credited against any earned royalties due for sales made in that year. The Licensee agrees to pay the IC earned royalties of ___ percent (X%) on Net Sales by or on behalf of Licensee or its sublicensees. The Licensee agrees to pay the IC Benchmark royalties within sixty (60) days of achieving each Benchmark: The Licensee agrees to pay the IC additional sublicensing royalties of ____ percent (X%) on the fair market value of any consideration received for granting each sublicense within sixty (60) days of the execution of each sublicense.
Sample 1Sample 2
APPENDIX C – ROYALTIES. Royalties: The Licensee agrees to pay to the IC a noncreditable, nonrefundable license issue royalty in the amount of _______ Dollars ($X) within sixty (60) days from the effective date of this Agreement. The Licensee agrees to pay to the IC a nonrefundable minimum annual royalty in the amount of _______ Dollars ($X) as follows: The first minimum annual royalty is due within sixty (60) days of the effective date of this Agreement and may be prorated according to the fraction of the calendar year remaining between the effective date of this Agreement and the next subsequent January 1; and Subsequent minimum annual royalty payments are due and payable on January 1 of each calendar year and may be credited against any earned royalties due for sales made in that year. The Licensee agrees to pay the IC earned royalties of ___ percent (X%) on Net Sales by or on behalf of the Licensee. The Licensee agrees to pay the IC Benchmark royalties within sixty (60) days of achieving each Benchmark:
Sample 1Sample 2
APPENDIX C – ROYALTIES. [This appendix has been redacted in its entirety]
Sample 1Sample 2
APPENDIX C – ROYALTIES. Royalties: LICENSEE agrees to pay to PHS a noncreditable, nonrefundable license issue royalty in the amount of [CONFIDENTIAL TREATMENT REQUESTED]. LICENSEE agrees to pay to PHS a nonrefundable minimum annual royalty in the amount of [CONFIDENTIAL TREATMENT REQUESTED]. LICENSEE shall pay PHS earned royalties at the rate of [CONFIDENTIAL TREATMENT REQUESTED] % on NET SALES of up to [CONFIDENTIAL TREATMENT REQUESTED] per annum and [CONFIDENTIAL TREATMENT REQUESTED] % on said NET SALES over [CONFIDENTIAL TREATMENT REQUESTED] per annum of LICENSED PRODUCTS made, used, or sold by LICENSEE and/or its SUBLICENSEES. LICENSEE agrees to pay PHS benchmark royalties as follows: ONCOLOGY [CONFIDENTIAL TREATMENT REQUESTED] at the completion of Phase 1 phenylbutyrate studies. Expected completion date – early 1996. [CONFIDENTIAL TREATMENT REQUESTED] at the completion of Phase II studies for either phenylbutyrate or phenylacetate. Expected completion date – late 1997 to early 1998. [CONFIDENTIAL TREATMENT REQUESTED] at the completion of Phase III studies for either phenylacetate or phenylbutyrate (whichever compound is found to be more efficacious) and filing of NDA. Expected completion date – late 2000. [CONFIDENTIAL TREATMENT REQUESTED] upon approval for the commercial sale of a Licensed Product, by the FDA or foreign functional equivalent, this royalty to apply only in the first country approved, if that country is the United States, Japan, or the first country in Europe. [CONFIDENTIAL TREATMENT REQUESTED] upon approval for the commercial sale of a Licensed Product by the FDA or foreign functional equivalent in subsequent countries approved, this royalty to apply only in the United States, in Japan, and the first country in Europe.
Sample 1Sample 2
APPENDIX C – ROYALTIES. Royalties: Licensee agrees to pay to PHS a noncreditable, nonrefundable license issue royalty in the amount of [*] Dollars ($[*]). Licensee agrees to pay to PHS a nonrefundable minimum annual royalty in the amount of [*] Dollars ($[*]) beginning January 1, 1999. Licensee agrees to pay PHS earned royalties on Net Sales by or on behalf of Licensee as follows: [*] Percent ([*]%) of Net Sales of Licensed Products by Licensee or its sublicensees; and Licensee shall be entitled to a [*] Percent ([*]%) credit against the earned royalty rate on Net Sales for each [*]Percent ([*]%) of royalty Licensee must pay in excess of [*] Percent ([*]%) to unaffiliated third party licensors for the manufacture and sale of Licensed Products. However, in no instance shall the earned royalty rate for PHS be reduced below [*] Percent ([*]%). Licensee agrees to pay PHS benchmark royalties as follows: [*] Dollars ($[*]) upon initiation of the first Phase III Clinical Trial for Licensed Products; and [*] Dollars ($[*]) upon marketing approval in the United States for Licensed Products. Licensee agrees to pay PHS additional royalties for unreimbursed patent prosecution expenses as set forth in Paragraphs 6.08 and 6.09.
Sample 1
AutoNDA by SimpleDocs
APPENDIX C – ROYALTIES. Royalties: The Licensee agrees to pay to the NIH a noncreditable, nonrefundable license issue royalty in the amount of ________ dollars ($X) within sixty (60) days from the effective date of this Agreement. The Licensee agrees to pay to the NIH a nonrefundable annual royalty in the amount of ________ dollars ($X) as follows: The first annual royalty is due within sixty (60) days of the effective date of this Agreement and may be prorated according to the fraction of the calendar year remaining between the effective date of this Agreement and the next subsequent January 1; and Subsequent annual royalty payments are due and payable on January 1 of each calendar year.
Sample 1

Related to APPENDIX C – ROYALTIES

  • Royalties 1. Royalties arising in a Contracting State and paid to a resident of the other Contracting State may be taxed in that other State.

  • Running Royalties Company shall pay to JHU a running royalty as set forth in Exhibit A, for each LICENSED PRODUCT(S) sold, and for each LICENSED SERVICE(S) provided, by Company or AFFILIATED COMPANIES, based on NET SALES and NET SERVICE REVENUES for the term of this Agreement. Such payments shall be made quarterly. All non-US taxes related to LICENSED PRODUCT(S) or LICENSED SERVICE(S) sold under this Agreement shall be paid by Company and shall not be deducted from royalty or other payments due to JHU. In order to insure JHU the full royalty payments contemplated hereunder, Company agrees that in the event any LICENSED PRODUCT(S) shall be sold to an AFFILIATED COMPANY or SUBLICENSEE(S) or to a corporation, firm or association with which Company shall have any agreement, understanding or arrangement with respect to consideration (such as, among other things, an option to purchase stock or actual stock ownership, or an arrangement involving division of profits or special rebates or allowances) the royalties to be paid hereunder for such LICENSED PRODUCT(S) shall be based upon the greater of: 1) the net selling price (per NET SALES) at which the purchaser of LICENSED PRODUCT(S) resells such product to the end user, 2) the NET SERVICE REVENUES received from using the LICENSED PRODUCT(S) in providing a service, or 3) the net selling price (per NET SALES) of LICENSED PRODUCT(S) paid by the purchaser. No multiple royalties shall be due or payable because any LICENSED PRODUCT(S) or LICENSED SERVICE(S) is covered by more than one claim of the PATENT RIGHTS or by claims of both the PATENT RIGHTS under this Agreement and “PATENT RIGHTS” under any other license agreement between Company and JHU. The royalty shall not be cumulative based on the number of patents or claims covering a product or service, but rather shall be capped at the rate set forth in Exhibit A.

  • Third Party Royalties Each party shall be responsible for all of its own costs of commercializing Products or licensing Intellectual Property Rights, including any payments to Third Parties for work done by such Third Parties or for licenses necessary for the manufacture, sale, or use of Products by a party or its Affiliates or sublicensees.

  • PATENTS AND ROYALTIES Unless otherwise provided, the Contractor shall be solely responsible for obtaining the right to use any patented or copyrighted materials in the performance of the contract resulting from this Invitation for Bids. The Contractor, without exception, shall indemnify and save harmless the County and its employees from liability of any nature or kind, including cost and expenses for or on account of any copyrighted, patented, or unpatented invention, process, or article manufactured or supplied by the Contractor. In the event of any claim against the County of copyright or patent infringement, the County shall promptly provide written notification to the Contractor. If such a claim is made, the Contractor shall use its best efforts to promptly purchase for the County any infringing products or services or procure a license, at no cost to the County, which will allow continued use of the service or product. If none of the alternatives are reasonably available, the County agrees to return the article on request to the Contractor and receive reimbursement, if any, as may be determined by a court of competent jurisdiction.

Time is Money Join Law Insider Premium to draft better contracts faster.